1,197
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Characterization of PLGA Microparticles as a Drug Carrier for 3-Ethoxycarbonyl-2H-Benzofuro[3,2-f]-1-Benzopyran-2-One. Ultrastructural Study of Cellular Uptake and Intracellular Distribution

, , , , , & show all
Pages 447-454 | Received 28 Aug 2005, Accepted 20 Dec 2005, Published online: 10 Oct 2008

Figures & data

TABLE 1 Mean diameter zeta potential and encapsulation efficiency of microparticles prepared by the solvent evaporation method

DIAG. 1. Representation of the typical psoralen (A) and psoralen A (3-ethoxy carbonyl-2H-benzofuro[3,2-f]-1-benzoyiran-2-one) (B).

DIAG. 1. Representation of the typical psoralen (A) and psoralen A (3-ethoxy carbonyl-2H-benzofuro[3,2-f]-1-benzoyiran-2-one) (B).

FIG. 1 Cumulative release profile of psoralen A from PLGA microparticle into buffer medium after 15 days.

FIG. 1 Cumulative release profile of psoralen A from PLGA microparticle into buffer medium after 15 days.

FIG. 2 Absorption spectrum of psoralen-loaded microparticle. The spectrum is deconvoluted into three components: (–)-deconvoluted absorption of psoralen A. Inset: (- - -)-glycerol and (—)-PLGA microparticle-psoralen in glycerol.

FIG. 2 Absorption spectrum of psoralen-loaded microparticle. The spectrum is deconvoluted into three components: (–)-deconvoluted absorption of psoralen A. Inset: (- - -)-glycerol and (—)-PLGA microparticle-psoralen in glycerol.

FIG. 3 Ultrastructural characterization of PLGA-microparticle loaded with psoralen A. (A) Representative SEM shows the surface of PLGA microparticle loaded with psoralen A (30000×). (B) PLGA-microparticle (SEM) (→)-phagocited by macrophage cell after incubation for 120 min (5000×). (C) Representative TEM of microparticle in incubation for 120 min peritoneal exudate cell population: neutrophil-Nϕ, eosinophil-Eo, hemacea-He, and selective phagocytose by macrophage-MC (3200×).

FIG. 3 Ultrastructural characterization of PLGA-microparticle loaded with psoralen A. (A) Representative SEM shows the surface of PLGA microparticle loaded with psoralen A (30000×). (B) PLGA-microparticle (SEM) (→)-phagocited by macrophage cell after incubation for 120 min (5000×). (C) Representative TEM of microparticle in incubation for 120 min peritoneal exudate cell population: neutrophil-Nϕ, eosinophil-Eo, hemacea-He, and selective phagocytose by macrophage-MC (3200×).

FIG. 4 Phagocytose of PLGA-microparticle loaded with psoralen A by macrophage peritoneal exudate. (A) PLGA microparticle (**) interacting with cellular membrane in the process of phagocytosis (15 min incubation). (B) Phagosome with PLGA microparticle (30 min incubation). (C) Psoralen A after microparticle digestion by macrophage (120 min incubation). (D) PLGA microparticle inside the macrophage cell, without irradiation (incubated for 120 min), mitochondria-Mi, lysosomes-Ly, nucleus (N), and granular endoplasmatic reticulum-Reg. (E) Photo-damage (PUVA) in macrophage cell with microparticle after 120 min incubation: cytoplasmic vesiculation, mitochondria condensation (Mi), and a swelling of granular endoplasmatic reticulum (Reg) and nuclear membrane (arrow) (12000×).

FIG. 4 Phagocytose of PLGA-microparticle loaded with psoralen A by macrophage peritoneal exudate. (A) PLGA microparticle (**) interacting with cellular membrane in the process of phagocytosis (15 min incubation). (B) Phagosome with PLGA microparticle (30 min incubation). (C) Psoralen A after microparticle digestion by macrophage (120 min incubation). (D) PLGA microparticle inside the macrophage cell, without irradiation (incubated for 120 min), mitochondria-Mi, lysosomes-Ly, nucleus (N), and granular endoplasmatic reticulum-Reg. (E) Photo-damage (PUVA) in macrophage cell with microparticle after 120 min incubation: cytoplasmic vesiculation, mitochondria condensation (Mi), and a swelling of granular endoplasmatic reticulum (Reg) and nuclear membrane (arrow) (12000×).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.